Quick Answer
Edesa Biotech, Inc. reported Net Income of -$7.19 million for fiscal year 2025.
Edesa Biotech, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$7.19M | -16.5% |
| 2024 | -$6.17M | +26.3% |
| 2023 | -$8.37M | +52.3% |
| 2022 | -$17.55M | -31.5% |
| 2021 | -$13.34M | -109.7% |
| 2020 | -$6.36M | -26.3% |
| 2018 | -$5.04M | -0.2% |
| 2017 | -$5.03M | -0.1% |
| 2016 | -$5.03M | -76.8% |
| 2015 | -$2.84M | -352.1% |
| 2014 | $1.13M | +113.4% |
| 2014 | -$8.44M | +41.8% |
| 2013 | -$14.50M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$2.25M | -39.0% | -28.5% |
| June 30, 2025 | -$1.75M | -4.9% | -10.0% |
| March 31, 2025 | -$1.59M | +14.6% | +1.7% |
| December 31, 2024 | -$1.62M | +3.6% | +3.1% |
| June 30, 2024 | -$1.67M | +16.0% | +10.4% |
| March 31, 2024 | -$1.86M | +20.3% | -10.9% |
| December 31, 2023 | -$1.68M | +28.1% | +15.4% |
| June 30, 2023 | -$1.98M | +65.7% | +15.0% |
- Edesa Biotech, Inc. showed a decrease of -16.5% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, Edesa Biotech, Inc.’s net income has grown by 50.4% (from -$14.50 million to -$7.19 million).
- The most recent figure is from Edesa Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 12, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: